Cargando…
MANAGEMENT OF ENDOCRINE DISEASE: Dysnatraemia in COVID-19: prevalence, prognostic impact, pathophysiology, and management
This review examines the prevalence, aetiology, pathophysiology, prognostic value, and investigation of dysnatraemia in hospitalised COVID-19 patients, taking into account all relevant studies published in PubMed and Cochrane Library studies until March 2021. Hyponatraemia is commonly observed in pa...
Autores principales: | Tzoulis, Ploutarchos, Grossman, Ashley B, Baldeweg, Stephanie E, Bouloux, Pierre, Kaltsas, Gregory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428074/ https://www.ncbi.nlm.nih.gov/pubmed/34370712 http://dx.doi.org/10.1530/EJE-21-0281 |
Ejemplares similares
-
Tolvaptan for the treatment of the syndrome of inappropriate
antidiuresis (SIAD)
por: Tzoulis, Ploutarchos, et al.
Publicado: (2023) -
Prevalence, prognostic value, pathophysiology, and management of hyponatraemia in children and adolescents with COVID-19
por: Tzoulis, Ploutarchos
Publicado: (2021) -
The management and outcome of hyponatraemia following transsphenoidal surgery: a retrospective observational study
por: Hussein, Ziad, et al.
Publicado: (2022) -
Improving care and outcomes of inpatients with syndrome of inappropriate antidiuresis (SIAD): a prospective intervention study of intensive endocrine input vs. routine care
por: Tzoulis, Ploutarchos, et al.
Publicado: (2016) -
The incidence, hospitalisations and deaths in acutely ill children with dysnatraemias
por: Lehtiranta, Saara, et al.
Publicado: (2022)